While families explore diet changes, supplements, and mind-body practices to manage ADHD, recent research highlights that standard treatments remain more effective, with alternative approaches showing limited conclusive benefits.
While some families turn to diet changes, supplements or mind-body practices in the hope of easing attention-deficit/hyperactivity disorder symptoms, the evidence remains uneven. The National Center for Complementary and Integrative Health says none of these approaches has been shown conclusively to work better than standard treatment, and experts advise speaking with a clinician before adding any complementary therapy. The Mayo Clinic gives similar advice, noting that research on alternative approaches is limited.
Food is one of the most common areas parents try to adjust. There is no official ADHD diet, but experts generally recommend a balanced eating pattern and caution against relying on sugar-heavy processed foods. Research has linked sugary drinks and snacks with worse behaviour in some children, although there is no evidence that sugar causes ADHD. The same guidance suggests limiting caffeine, particularly for children or for anyone already taking stimulant medicine, because the combination can worsen jitters, stomach upset and sleep problems.
Omega-3 supplements are often discussed as a possible aid, but the science is mixed. The NCCIH says some studies suggest a modest benefit, while others find no clear improvement, and it notes that standard stimulant medicines remain more effective. Even so, omega-3 fats from food, such as salmon and walnuts, are generally considered valuable for brain and heart health. Some reviews also suggest that fish oil may be more useful than DHA alone, though the evidence is still preliminary.
Other approaches include yoga, mindfulness and neurofeedback, a method that uses sensors to track brain-wave activity while a person completes tasks. Mayo Clinic says these therapies have been tried, but not fully proven. A newer option is EndeavorRx, a game-based digital therapeutic that the Food and Drug Administration cleared in 2020 for children ages 8 to 12 with primarily inattentive or combined-type ADHD. According to the FDA, it is meant to be used alongside a broader care plan rather than as a stand-alone treatment.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.





